Elon Musk's Neuralink gets U.S. FDA approval for human clinical study of brain implants

05/25/2023 | 06:36pm

(Reuters) - Elon Musk's brain-implant company Neuralink on Thursday said it received U.S. Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.

(Reporting by Akriti Sharma in Bengaluru; Editing by Anil D'Silva)

2d ago	Elon Musk's whirlwind China trip included talks with vice premier
3d ago	Elon Musk greeted with flattery and feasts during China trip
4d ago	Elon Musk kicks off China visit, Tesla expansion in focus
5d ago	Musk expected to visit China this week, meet officials - sources
05/25	Elon Musk's Neuralink gets U.S. FDA approval for human clinical study of...